Piper Jaffray
Piper Jaffray is a client-focused, middle market investment bank and institutional securities firm founded in 1895 and based in Minneapolis, Minnesota.
Its Investment Banking activities include raising capital through equity and debt financings for corporate clients; providing financial advisory services relating to mergers and acquisitions to consumer, financial institutions, health care, technology, alternative energy, business services, and industrial growth sectors; underwriting debt issuances for government and non-profit clients; and providing financial advisory and interest rate risk management services.
The company's equity and fixed income institutional sales and trading activities include equity and fixed income advisory and trade execution services for public and private corporations, public entities, non-profit clients, and institutional investors.
-
Piper Jaffray Upgrades Genentech (DNA) to Buy, Valuation Compelling Whether Roche Acquires or Not
-
David Moenning's Daily State of the Markets: 7/22
-
Piper Jaffray Downgrades Genentech (DNA) to Neutral; Valuation Suggests Roche Needs to Raise Bid
-
David Moenning's Daily State of the Markets: 7/17
-
Piper Jaffray Raises Estimates on Genentech; PT from $86 to $92 (DNA)
